Possible medications to treat or manage T2DM include oral hypoglycemic agents, such as sulfonylureas; a third class of agent that binds to PPARG to reduce insulin resistance; and a fourth class that acts on the intestinal absorption of glucose. This evidence concerns the gene PPARG and type 2 diabetes mellitus.